Clinical Trials Browser

Phase 4 × Tirzepatide × 90 days × Clear all

NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Phase 4 Not yet recruiting

Breast Neoplasms, Obesity